Disc Regeneration Composition to Replace Heterogeneous NCCM
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current interventions for degenerative disc disease (DDD) are inadequate, and surgical procedures like spinal fusion can exacerbate the condition, while existing treatments such as notochordal cell-derived conditioned medium (NCCM) are heterogeneous and lack clarity on their beneficial effects.
Innovation Solution
A composition comprising chondroitin sulfate, glucosamine hydrochloride, connective tissue growth factor (CTGF), transforming growth factor beta 1 (TGFβ1), and optional components like dextrose and carboxymethylcellulose, administered directly to the disc to promote regenerative therapies.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If notochordal cell-derived conditioned medium (NCCM) is used to treat disc degeneration, then anabolic effects and proteoglycan synthesis are enhanced, but the treatment lacks homogeneity and clarity regarding beneficial effects
Solution Approach 1:
The patent extracts and identifies the specific beneficial components (CTGF and TGFβ1) from the heterogeneous NCCM mixture. By isolating these active factors, the treatment achieves reliable anabolic effects while eliminating the compositional heterogeneity and uncertainty associated with using whole NCCM.
Solution Approach 2:
The patent changes the composition parameters by defining specific concentration ranges for CTGF (50-500 ng/mg) and TGFβ1 (10-100 ng/mg). This parameter specification transforms the treatment from a heterogeneous mixture to a controlled composition with predictable and reliable therapeutic effects.
2Strength
If spinal fusion surgery is performed to treat disc degeneration, then structural support is restored, but adjacent segment degeneration is accelerated
Solution Approach 1:
The patent enables the disc tissue to repair and regenerate itself by delivering growth factors (CTGF and TGFβ1) that stimulate native cell activity. This self-service approach restores disc function without the need for fusion surgery, thereby avoiding the harmful effect of accelerating adjacent segment degeneration while still providing structural support.
3Productivity
If a composition with high concentrations of growth factors is used to promote disc regeneration, then cell proliferation and matrix restoration are enhanced, but the risk of adverse effects increases
Solution Approach 1:
The patent optimizes the concentration parameters of CTGF (50-500 ng/mg) and TGFβ1 (10-100 ng/mg) to achieve effective disc regeneration while minimizing adverse effects. These controlled parameter ranges enable high productivity in terms of cell proliferation and matrix restoration without exceeding safe thresholds that could cause harmful side effects.
Data Source
AI summary
There is disclosed herein compositions, methods, uses and systems for reducing pain in a patient that emanates from a body area, preferably spine or joint. Methods of treatment or prevention are described for a disease or condition selected from degenerative disc disease, disc injury, pain, arthritis, or suspected arthritis.